Alkermes reiterates its financial expectations for 2023, as set forth on February 2023.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ALKS:
- Alkermes arbitration award better than expected, says Mizuho
- Alkermes price target raised to $31 from $29 at JPMorgan
- Alkermes receives second interim award in Janssen arbitration
- Alkermes submits Form 10 to SEC for planned separation of oncology business
- Alkermes price target raised to $37 from $36 at Mizuho